News
Reflecting on a milestone year: Prescient Therapeutics readies for next stage in cancer battle
Australian biotech company Prescient Therapeutics has achieved numerous milestones in the past financial year as it advances the development of its cancer-fighting treatments.
Paying it back: Harvey Norman refunds JobKeeper payments after reporting strong profits
Furniture and electronics retailer Harvey Norman has repaid more than $6 million in JobKeeper subsidies amid a mounting public backlash against businesses profiting after receiving the payments.
Australia’s knife-edge balancing act to avoid second recession in a year
Australia appears to be right on the cusp of a technical recession in the June quarter, with forecast GDP figures sitting dangerously close to zero.
Note from the MD: Markets tipped to ease after cracking 73 year old record
Markets have dipped on open this morning after Wall Street slipped over night – even so, Australian markets have been on a tear of late as we move into September off the back of a record-breaking August.
Alex Waislitz: Australian stock market reporting season delivers the goods
Despite a difficult year fraught with new challenges, many Australia’s listed companies are emerging from the reporting season in good health, according to Alex Waislitz.
The $US4.68 billion market that could be about to replace the Cloud
70% of businesses have at least one application on the Cloud, but some experts believe a new and better technology could already be about to replace it.
Gaming the system: Auction house accused of fraud following record-breaking video game sales
The auction house at the centre of several record-breaking vintage video game sales has been accused of conspiring with a grading company to artificially inflate prices.
Is transport technology the solution to COVID-19 breaches?
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. Joel Fleming from Yarra Capital Management selected Eroad Limited (ASX: ERD) as one of his 3 favourite stocks, which grew 8% across…
‘Revolutionary’ device transforms maternal health
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. Shaun Cartwright from Viriathus Australia selected HeraMED Limited (ASX: HMD) as one of his 3 favourite stocks, as the demand for telehealth…
Note from the MD: Markets looking up after record breaking night on Wall Street
Things are looking up this morning after the Nasdaq and S&P 500 both broke to new highs in trading overnight, with the Dow Jones sitting pretty close to record levels too.
Thorney Investment Group’s Alex Waislitz discusses investing during a ‘challenging’ year
Rising geopolitical tensions, ‘draconian’ lockdowns across the country and a market flush with easy cash have made the last 12 months an interesting time for investors, according to Alex Waislitz.
Prescient Therapeutics snags global brain cancer authority for advisory board
Prescient Therapeutics has announced that a global expert in brain cancer, Professor Donald M. O’Rourke, will be joining the company’s Scientific Advisory Board.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.